Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

Keyphrases

• Albuminuria 100%
• Advanced Glycation End Products 100%
• Glomerular Sclerosis 100%
• Aminoguanidine 25%
• Albumin 25%
• Glomerulosclerosis 25%
• Aging 16%
• Diabetes 16%
• Product Level 16%
• Advanced Glycation End-products Inhibitor 16%
• Light Microscopy 8%
• Electron Microscopy 8%
• Diabetic 8%
• Kidney 8%
• Extracellular Matrix 8%
• Protein Modification 8%
• Mesangium 8%
• Basement Membrane 8%
• Co-treatment 8%
• Structural Defects 8%
• Significant Loss 8%
• Renal Tissue 8%
• Product-specific 8%
• Glomerular Function 8%
• Glomerular Volume 8%
• Product Content 8%
• Periodic acid-Schiff 8%
• Nephrosclerosis 8%
• Healthy Rats 8%
• Schiff's Reagent 8%
• Glomerular Structure 8%
• Pathogenic Role 8%
• In Vivo Data 8%
• Functional Defects 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Albuminuria 100%
• Advanced Glycation End Product 100%
• Glomerulosclerosis 100%
• Aminoguanidine 21%
• Electron Microscopy 7%
• Periodic Acid 7%
• Glycine Dehydrogenase (Decarboxylating) 7%
• Nephrosclerosis 7%
• Diabetes Mellitus 7%

Neuroscience

• Advanced Glycation End Product 100%
• In Vivo 7%
• Electron Microscopy 7%
• Basement Membrane 7%
• Glycine Dehydrogenase (Decarboxylating) 7%
• Extracellular Matrix 7%
• Diabetes Mellitus 7%